AOA is a biotech company developing cancer diagnostics in the field of women’s health.
AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission is to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 15, 2021 | Seed | $2.50M | 1 | — | — | Detail |
Jun 28, 2021 | Seed | $2.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
TBD Angels | — | Seed |